Live Breaking News & Updates on Consensus

Stay informed with the latest breaking news from Consensus on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Consensus and stay connected to the pulse of your community

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $38.57 Consensus Price Target from Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year […]

Melissab-epperly , Insider-transactions-at-zentalis-pharmaceuticals , Decheng-capital , Zentalis-pharmaceuticals-price-performance , Nasdaq , Institutional-investors-weigh-in-on-zentalis-pharmaceuticals , News-ratings-for-zentalis-pharmaceuticals-daily , Vanguard-group-inc , Rafferty-asset-management , Zentalis-pharmaceuticals-inc , Hermes-inc

Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Target Price at $38.57

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […]

China , Melissab-epperly , Securities-exchange-commission , Exchange-traded-concepts , Zentalis-pharmaceuticals-stock , China-universal-asset-management-co , Quest-partners , Nasdaq , News-ratings-for-zentalis-pharmaceuticals-daily , Zentalis-pharmaceuticals-inc , Analyst-recommendations-for-zentalis-pharmaceuticals

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Rating of "Buy" by Analysts

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have updated their coverage on the stock in the last […]

Mark-mcdade , Jefferies-financial-group , Nasdaq , Capital-management , Denali-advisors , Affinity-asset-advisors , Tourmaline-bio-inc , Jump-financial , Tourmaline-bio , Get-free-report , Financial-group , Truist-financial

Jabil Inc. (NYSE:JBL) Given Consensus Rating of "Buy" by Brokerages

Shares of Jabil Inc. (NYSE:JBL – Get Free Report) have been assigned a consensus rating of “Buy” from the seven brokerages that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the […]

United-kingdom , Kenneths-wilson , Electronics-manufacturing-services , Manufacturing-services , Barclays , Field-main-bank , Jabil-company-profile , Securities-exchange-commission , Gulf-international-bank-united-kingdom-ltd , Jabil-inc , Advisors-inc

Enhabit, Inc. (NYSE:EHAB) Receives $12.08 Consensus Price Target from Analysts

Enhabit, Inc. (NYSE:EHAB – Get Free Report) has been given an average rating of “Reduce” by the seven analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average […]

United-states , Financial-services-group-inc , Allspring-global-investments-holdings , Summerhaven-investment-management , Enhabit-inc , Brooks-moore-associates-inc , Jefferies-financial-group , Enhabit-company-profile , Get-free-report , Haven-investment-management , Services-group

Brokerages Set DoorDash, Inc. (NASDAQ:DASH) Target Price at $128.88

DoorDash, Inc. (NASDAQ:DASH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 1 year price target among brokerages […]

United-states , Piper-sandler , Andy-fang , Shonal-brown , Roth-mkm , Third-bancorp , Covestor-ltd , Investment-consulting-inc , Doordash-inc , Nasdaq , Goldman-sachs-group , Parkside-financial-bank

Brokerages Set América Móvil, S.A.B. de C.V. (NYSE:AMX) PT at $22.57

Shares of América Móvil, S.A.B. de C.V. (NYSE:AMX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have assigned a […]

United-states , America , Jpmorgan-chase-co , Lazard-asset-management , Goldman-sachs-group , Capital-international-investors , Westwood-global-investments , Jefferies-financial-group , Invesco-ltd , Schroder-investment-management-group , Get-free-report

América Móvil, S.A.B. de C.V. (NYSE:AMX) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of América Móvil, S.A.B. de C.V. (NYSE:AMX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and six have assigned […]

United-states , America , P-morgan-private-wealth-advisors , Vestmark-advisory-solutions-inc , Envestnet-portfolio-solutions-inc , Income-strategies , Jpmorgan-chase-co , Goldman-sachs-group , Jefferies-financial-group , Newedge-wealth , Get-free-report

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of "Buy" by Brokerages

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average recommendation of “Buy” from the nine analysts that are covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year […]

Wellington , New-zealand-general- , New-zealand , Blackstone-inc , Cantor-fitzgerald , Cabaletta-bio-inc , Cabaletta-bio-company-profile , Victory-capital-management-inc , Wells-fargo-company , Nasdaq , Wellington-management-group

Enhabit, Inc. (NYSE:EHAB) Receives $12.08 Average Price Target from Brokerages

Shares of Enhabit, Inc. (NYSE:EHAB – Get Free Report) have received a consensus rating of “Reduce” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the […]

United-states , Enhabit-inc , Deerfield-management-companylp-series , Enhabit-company-profile , Jefferies-financial-group , Schroder-investment-management-group , Ancora-advisors , Get-free-report , Marketbeat-ratings , Financial-group , Capital-management